Kodiak Sciences KOD
NASDAQ KOD
$35.72 -0.64 (-1.76%)
As of: Sep 4, 2026 · 3:20 PM EDT

Kodiak Sciences (KOD) Profit After Tax (2017 - 2026)

Kodiak Sciences' (KOD) quarterly Profit After Tax came in at -$58.2 million in Q1 2026, down 1.21% YoY from -$58.9 million in Q1 2025, and down 133.58% on a QoQ basis from $173.2 million in Q4 2025.

Analysis

Kodiak Sciences (KOD) Profit After Tax (2017 - 2026) Analysis & Trends

Kodiak Sciences (KOD) has 10 years of Profit After Tax data on file, last reported at -$58.2 million in Q1 2026.

  • Quarterly Profit After Tax fell 1.21% year-over-year to -$58.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$728000.0 (up 99.62% YoY) and the FY2024 annual result came in at -$176.2 million, up 32.36% from the prior year.
  • Profit After Tax fell to -$58.2 million in Q1 2026, from $173.2 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $262.1 million in Q4 2022 to a low of -$95.7 million in Q1 2022.
  • A 5-year average of -$13.1 million and a median of -$44.6 million in 2024 frame the typical range for Profit After Tax.
  • Annual changes were most pronounced in 2022 — Profit After Tax slumped 10283.33% — and 2025, when it jumped 492.76%.
  • Tracing KOD's Profit After Tax over 5 years: stood at $262.1 million in 2022, then tumbled by 123.21% to -$60.8 million in 2023, then grew by 27.5% to -$44.1 million in 2024, then jumped by 492.76% to $173.2 million in 2025, then tumbled by 133.58% to -$58.2 million in 2026.
  • The last three Profit After Tax figures came in at -$58.2 million (Q1 2026), $173.2 million (Q4 2025), and -$61.5 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn 472.00 Mn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn - -644.37 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 81.49 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -16.62 Mn
10 Kodiak Sciences 2.23 Bn 2.23 Bn - -65.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -65.64 Mn
Mar 31, 2026 -58.16 Mn
Dec 31, 2025 -56.77 Mn
Sep 30, 2025 -61.46 Mn
Jun 30, 2025 -54.31 Mn
Mar 31, 2025 -57.46 Mn
Dec 31, 2024 -44.11 Mn
Sep 30, 2024 -43.95 Mn
Jun 30, 2024 -45.12 Mn
Mar 31, 2024 -43.04 Mn
Dec 31, 2023 -59.53 Mn
Sep 30, 2023 -50.01 Mn
Jun 30, 2023 -80.19 Mn
Mar 31, 2023 -70.78 Mn
Dec 31, 2022 -69.25 Mn
Sep 30, 2022 -77.67 Mn
Jun 30, 2022 -90.63 Mn
Mar 31, 2022 -95.71 Mn
Dec 31, 2021 -93.17 Mn
Sep 30, 2021 -67.53 Mn